INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Auwaerter Paul Gisbert reported CAPR

Director · CAPRICOR THERAPEUTICS, INC. · CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)

Side
A
Value
—
Shares
15.5K
Price
—
Executed
Jan 5, 2026
Disclosed
Jan 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 5 executedJan 7, 2026 disclosed

CAPR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CAPR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    MT
    Maurer Michael TCHIEF COMMERCIAL OFFICER
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    80.0K sh
    		May 26, 2026May 28, 2026
    traded May 26, 2026
    		+2dSEC FORM 4

    Evidence

    26
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Open-market sale · 10b5-1 plan
    		SELL$1.85M
    61.3K sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    5
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M$298K
    61.3K sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    1
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M$261K
    53.7K sh
    		Apr 1, 2026Apr 1, 2026
    traded Apr 1, 2026
    		+0dSEC FORM 4

    Evidence

    22
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Open-market sale · 10b5-1 plan
    		SELL$1.67M
    53.7K sh
    		Apr 1, 2026Apr 1, 2026
    traded Apr 1, 2026
    		+0dSEC FORM 4

    Evidence

    0
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    61.3K sh
    		Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    		+1dSEC FORM 4

    Evidence

    0
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Option exercise · 10b5-1 plan
    		M—
    53.7K sh
    		Apr 1, 2026Apr 1, 2026
    traded Apr 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    AG
    Auwaerter Paul GisbertDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    1,360 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AG
    Auwaerter Paul GisbertDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    5,420 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    GJ
    Gotwals Philip JDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SE
    Sabar Karimah EsDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KM
    Kelliher MikeDirector
    CAPRCAPRICOR THERAPEUTICS, INC.
    Grant or award
    		A—
    15.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001982730-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 5, 2026
    Published
    Jan 7, 2026
    Ingested by INSIDER
    Nov 5, 04:24 UTC
    Last re-read
    Nov 5, 04:24 UTC

    Extracted facts

    Filer
    Auwaerter Paul Gisbert
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)
    Ticker
    CAPR
    Shares
    15.5K
    Price per share
    $0
    Execution date (reported)
    Jan 5, 2026
    Owned after transaction
    15.5K shares
    Days from execution to publication
    2

    What this establishes

    Auwaerter Paul Gisbert filed this Form 4 reporting a grant or award of CAPR on Jan 5, 2026. It became public on Jan 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Auwaerter Paul Gisbertcik:0001982730
    Issuer
    CAPRICOR THERAPEUTICS, INC.cik:0001133869

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.